Skip to main content

Volume 17 Supplement 2

An overview of “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network

Proceedings

Symposium was sponsored by Riga Stradins University (RSU), Riga, Latvia; Peoples Friendship University of Russia (RUDN University); R&D companies "BD Biosciences" and "Helicon"; research journals "Infectious Agents and Cancer" (BMC, Spinger Nature) and "Cancers" (MDPI, Bazel) and by the Virtual Mobility Grant of the European Network of Vaccine Adjuvants ENOVA COST Action CA16231 to M. Isaguliants at RSU, Riga, Latvia.

VirtualDecember 16-17, 2021

Edited by Maria Isaguliants, Natalia Petrakova and Franco Buonaguro.


  1. This is a report on the research activities currently ongoing in virology, oncology and virus-associated cancers and possibilities of their treatment and prevention by vaccines and immunotherapies as outlined ...

    Authors: Maria G. Isaguliants, Ivan Trotsenko and Franco M. Buonaguro
    Citation: Infectious Agents and Cancer 2022 17(Suppl 2):28
    Content type: Proceedings Published on:

Follow

Annual Journal Metrics

What is trending?

Altmetric




               Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us